Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent

Launched by PHILLIP FREEMAN · May 14, 2019

Keywords

ClinConnect Summary

The SORT OUT XI clinical trial is exploring two different types of stents, which are small mesh tubes used to keep blocked arteries open, for patients with coronary artery disease. Specifically, the study is comparing the Combo™ stent and the BioMatrix Alpha™ stent to see which one works better in treating heart disease. This trial is currently active but not recruiting new participants.

To be eligible for this study, you need to be at least 18 years old and suitable for treatment with drug-eluting coronary stents, which help prevent arteries from becoming blocked again. However, if you are younger than 18, unable to give consent, do not speak Danish, or have a life expectancy of less than one year, you would not qualify for this trial. If you decide to participate, you'll receive one of the stents, and the research team will monitor your health to learn more about the effectiveness of these stents in improving heart health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients aged ≥18 years who are eligible for treatment with one or several drug-eluting coronary stents at one of the three heart centers in Aarhus, Odense and Aalborg can be included in the study.
• Exclusion Criteria:
• • Age \< 18 years
• • The patient does not wish to participate
• • The patient is not able to consent to randomization (eg. intubated patients)
• • The patient do not speak Danish
• • The patient is already included in the SORT OUT XI study
• • Life expectancy \<1 year
• • Allergic to study related treatment